|
|||||
|
|
Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies |
|
| Authors: | Lina Adwan Gehad M. Subaiea Riyaz Basha Nasser H. Zawia |
| Affiliation: | 1. Department of Biomedical & Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island, USA;2. Department of Pediatrics, Molecular & Medical Genetics, Institute for Cancer Research, University of North Texas Health Science Center, Fort Worth, Texas, USA;3. Interdisciplinary Neuroscience Program, University of Rhode Island, Kingston, Rhode Island, USA |
| Abstract: | |
| Keywords: | Alzheimer's disease cyclin‐dependent kinase‐5 Sp1 tau therapy tolfenamic acid |